For some older adults, the flu vaccine could look a little different this year. In August, the U.S. Food and Drug ...
This article originally appeared on the Bloomberg School of Public Health website. An mRNA flu vaccine is on its way. On Aug. 5, the U.S. Food and Drug Administration approved Moderna's mFLUSIVA, the ...
LIBERTY is a Phase 3, randomized, double-blind clinical trial to evaluate the safety, serum virus neutralizing antibody responses, and pharmacokinetics of VYD2311, an mRNA COVID vaccine, and ...
On 5 August, the US Food and Drug Administration (FDA) granted approval to Moderna’s mRNA-based flu vaccine, mFLUSIVA, for adults aged 50–64, and accelerated approval for adults aged 65 and older.
Add Yahoo as a preferred source to see more of our stories on Google. Moderna says it expects to have the new mRNA-based flu vaccine available for adults 50 and older this fall. - Graham ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results